Keyphrases
Adverse Events
63%
Adverse Impact
21%
Atrial Fibrillation
26%
Bayesian Hierarchical Model
42%
Bayesian Modeling
26%
Berries
25%
Bleeding Risk
21%
Body Image Dissatisfaction
21%
Body Systems
31%
Bowel Cancer Screening
21%
Cancer Diagnosis
21%
Cardiovascular Disease
35%
Cardiovascular Prevention
42%
Cardiovascular Risk Management
42%
Clinical Trials
85%
Colorectal Cancer Screening
21%
Confidence Interval
35%
COVID-19 Pandemic
23%
COVID-19 Pandemic Impact
21%
Direct Oral Anticoagulants
65%
Error Rate
21%
Hazard Ratio
33%
Low Incidence
21%
Medication Information
28%
Meta-analysis
21%
Multicenter Observational Study
21%
Multiple Comparisons
29%
Multiple Outcomes
42%
Obstructive Sleep Apnea
21%
Oral Anticoagulants
42%
Pathological Diagnosis
21%
Pathologist
28%
Population Scale
21%
Progression-free Survival
21%
Randomized Controlled Trial
45%
Record Linkage Study
21%
Relapsed or Refractory multiple Myeloma
21%
Retrospective Cohort Study
44%
Routinely Collected Healthcare Data
42%
Safety Signal
63%
Scotland
100%
Serrated Polyps
28%
Statistical Analysis
34%
Stroke Risk
42%
Subtype Diagnosis
21%
System Organ Class
52%
Trend Analysis
21%
Vitamin K Antagonists
30%
Wales
28%
Western European Countries
21%
Medicine and Dentistry
Acetylsalicylic Acid
7%
Antithrombotic
42%
Apoplexy
50%
Atrial Fibrillation
24%
Bariatric Surgery
42%
Bleeding
21%
Body Image
21%
Body Mass Index
21%
Bowel Cancer Screening
25%
Cancer
21%
Cardiovascular Disease
42%
Cardiovascular Disease Prevention
42%
Cardiovascular Disease Risk Factor
7%
Cerebral Hemorrhage
9%
Cohort Analysis
5%
Colonoscopy
8%
Colorectal Cancer Screening
21%
Colorectal Polyp
9%
Comorbidity
7%
COVID-19
42%
Diabetes
14%
Direct Oral Anticoagulant
36%
Disease Management
42%
Endoscopy
8%
Gene Linkage
28%
Hazard Ratio
23%
Health Technology
21%
Major Bleeding
5%
Malignant Neoplasm
8%
Medicine
28%
Meta-Analysis
21%
Morbid Obesity
10%
Multiple Myeloma
21%
Observational Study
24%
Obstructive Sleep Apnea
21%
Overall Survival
17%
Pathologist
25%
Patient with Obesity
10%
Polyp
33%
Pomalidomide
21%
Progression Free Survival
21%
Quality of Life
7%
Randomized Clinical Trial
10%
Retrospective Cohort Study
55%
Roux-en-Y Gastric Bypass
35%
Screening
32%
Sleeve Gastrectomy
38%
Systematic Review
21%
Technology Assessment
21%
Vitamin K Antagonist
32%